Evaluation of the effects of a high dose of erythropoietin-beta on early endotoxemia using a rat model

Advances in Clinical and Experimental Medicine

Volumn 21, Issue 3, 2012, Pages 321-329

  Eren, Zehra ^a   Çoban, Jale ^a   Ekinci, Işin D ^a   Kaspar, Cigdem ^a   Kantarci, Gülçin ^a  

^a YEDITEPE UNIVERSITY   (Turkey)

Author keywords

Acute kidney injury; Endotoxemia; Erythropoietin; Lipopolysaccharide

Indexed keywords

C REACTIVE PROTEIN; CASPASE 9; CREATININE; CYTOKINE; ERYTHROPOIETIN; ERYTHROPOIETIN BETA; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD CELL COUNT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG MEGADOSE; ENDOTOXEMIA; IMMUNOCOMPETENT CELL; KIDNEY FUNCTION; KIDNEY INJURY; LEUKOCYTE COUNT; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; THROMBOCYTE COUNT; UREA BLOOD LEVEL;

BACTERIA (MICROORGANISMS); RATTUS;

EID: 84863753585     PISSN: 18995276     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Muntner P, Warnock DG: Acute kidney injury in sepsis: questions answered, but others remain. Kidney Int 2010, 77, 485-487.
2. Cunningham PN, Dyanov HM, Park P, Wang J, Newell KA, Quigg RJ: Acute renal failure in endotoxemia is caused by TNF acting directly on TNF receptor-1 in kidney. J Immunol 2002, 168, 5817-5823. (Pubitemid 34556169)
3. Villa P, Sartor G, Angelini M, Sironi M, Conni M, Gnocchi P, Isetta AM, Grau G, Buurman W, van Tits LJ et al.: Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin. Clin Diagn Lab Immunol 1995, 2, 549-553.
4. Arcasoy MO: Non-erythroid effects of erythropoietin. Haematologica 2010, 95, 1803-1805.
5. Brines M, Cerami A: Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J Intern Med 2008 Nov, 264(5), 405-432. Review.
6. Sharpies EJ, Yaqoob MM: Erythropoietin in experimental acute renal failure. Nephron Exp Nephrol 2006, 104, 83-88.
7. Yamada M, Burke C, Colditz P, Johnson DW, Gobe GC: Erythropoietin protects against apoptosis and increases expression of non-neuronal cell markers in the hypoxia-injured developing brain. J Pathol 2011, 224, 101-109.
8. Shang Y, Li X, Prasad PV, Xu S, Yao S, Liu D, Yuan S, Feng D: Erythropoietin attenuates lung injury in lipopolysaccharide treated rats. J Surg Res 2009, 155, 104-110.
9. Le Minh K, Klemm K, Abshagen K, Eipel C, Menger MD, Vollmar B: Attenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-alpha in acute liver failure of mice. Am J Pathol 2007, 170, 1954-1963. (Pubitemid 47339269)
10. Vesey DA, Cheung C, Pat B, Endre Z, Gobé G, Johnson DW: Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004, 19, 348-355. (Pubitemid 38195983)
11. Sølling C, Christensen AT, Krag S, Frøkiaer J, Wogensen L, Krog J, Tønnesen EK: Erythropoietin administration is associated with short-term improvement in glomerular filtration rate after ischemia-reperfusion injury. Acta Anaesthesiol Scand 2011, 55, 185-195.
12. Ishii Y, Sawada T, Murakami T, Sakuraoka Y, Shiraki T, Shimizu A, Kubota K, Fuchinoue S, Teraoka S: Renoprotective effect of erythropoietin against ischaemia-reperfusion injury in a non-human primate model. Nephrol Dial Transplant 2011, 26, 1157-1162.
13. Salahudeen AK, Haider N, Jenkins J, Joshi M, Patel H, Huang H, Yang M, Zhe H: Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury. Am J Physiol Renal Physiol 2008, 294, 1354-1365.
14. Yokomaku Y, Sugimoto T, Kume S, Araki S, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Nitta N, Haneda M, Koya D, Uzu T, Kashiwagi A: Asialoerythropoietin prevents contrast-induced nephropathy. J Am Soc Nephrol 2008, 19, 321-328. (Pubitemid 351246572)
15. Abdelrahman M, Sharpies EJ, McDonald MC, Collin M, Patel NS, Yaqoob MM, Thiemermann C: Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 2004, 22, 63-69. (Pubitemid 40228212)
16. De Vriese AS: Prevention and treatment of acute renal failure in sepsis. J Am Soc Nephrol 2003, 14, 792-805.
17. Schmidt C, Höcherl K, Bucher M: Cytokine-mediated regulation of urea transporters during experimental endotoxemia. Am J Physiol Renal Physiol 2007, 292, 1479-1489.
18. Schrier RW, Wang W: Acute renal failure and sepsis. N Engl J Med 2004, 351, 159-169.
19. Johannes T, Ince C, Klingel K, Unertl KE, Mik EG: Iloprost preserves renal oxygenation and restores kidney function in endotoxemia-related acute renal failure in the rat. Crit Care Med 2009, 37, 1423-1432.
20. Zager RA, Johnson AC, Lund S, Hanson SY, Abrass CK: Levosimendan protects against experimental endotoxemic acute renal failure. Am J Physiol Renal Physiol 2006, 290, 1453-1462.
21. Wang W, Faubel S, Ljubanovic D, Mitra A, Falk SA, Kim J, Tao Y, Soloviev A, Reznikov LL, Dinarello CA, Schrier RW, Edelstein CL: Endotoxemic acute renal failure is attenuated in caspase-1-deficient mice. Am J Physiol Renal Physiol 2005, 288, 997-1004.
22. Brines M: The therapeutic potential of erythropoiesis-stimulating agents for tissue protection: a tale of two receptors. Blood Purif 2010, 29, 86-92.
23. Mitra A, Bansal S, Wang W, Falk S, Zolty E, Schrier RW: Erythropoietin ameliorates renal dysfunction during endotoxaemia. Nephrol Dial Transplant 2007, 22, 2349-2353. (Pubitemid 47244715)
24. Aoshiba K, Onizawa S, Tsuji T, Nagai A: Therapeutic effects of erythropoietin in murine models of endotoxin shock. Crit Care Med 2009, 37, 889-898.
25. Wu WT, Hu TM, Lin NT, Subeq YM, Lee RP, Hsu BG: Low-dose erythropoietin aggravates endotoxin-induced organ damage in conscious rats. Cytokine 2010, 49, 155-162.
26. Digicaylioglu M, Lipton SA: Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 2001, 412, 641-647. (Pubitemid 32772276)
27. Westenfelder C, Biddle DL, Baranowski RL: Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int 1999, 55, 808-820. (Pubitemid 29100693)
28. Jelkmann W: Erythropoietin after a century of research: younger than ever. Eur J Haematol 2007, 78, 183-205.
29. Lin X, Qu S, Hu M, Jiang C: Protective effect of erythropoietin on renal injury induced by acute exhaustive exercise in the rat. Int J Sports Med 2010, 31, 847-853.
30. Villa P, Sartor G, Angelini M, Sironi M, Conni M, Gnocchi P, Isetta AM, Grau G, Burman W, Tits LJH, Ghezzi P: Pattern of cytokines and pharmacomodulation in sepsis induced by cecal ligation and puncture compared with that induced by endotoxin. Clin Diagn Lab Immunol 1995, 2, 549-553.
31. Xia D, Samols D: Transgenic mice expressing rabbit C-reactive protein are resistant to endotoxemia. Proc Natl Acad Sci USA 1997, 94, 2575-2580. (Pubitemid 27136917)
32. Ehrenreich H, Weissenborn K, Prange H, Schneider D, Weimar C, Wartenberg K, Schellinger PD, Bohn M, Becker H, Wegrzyn M, Jähnig P, Herrmann M, Knauth M, Bähr M, Heide W, Wagner A, Schwab S, Reichmann H, Schwendemann G, Dengler R, Kastrup A, Bartels C: EPO Stroke Trial Group. Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 2009, 40, 647-656.